Imaging Study of Lead Implant for His Bundle Pacing ((IMAGE-HBP))

Imagining Study of Lead Implant for His Bundle Pacing

The purpose of this research study is to assess the implant success proportion of the Medtronic SelectSecure MRI SureScan Model 3830 pacing lead at the bundle of His for His bundle pacing.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study will evaluate implant lead electrical measurements and changes over time, estimate the correlation between lead location and selective vs non-selective His bundle pacing, and estimate the correlation between long-term lead performance and implant characteristics. Data from the study may be used to standardize the implant workflow to help improve the ease and predictability of His bundle pacing implants.

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Indiana University - Krannert Institute of Cardiology
    • Pennsylvania
      • Wilkes-Barre, Pennsylvania, United States, 18711
        • Geisinger Wyoming Valley Medical Center
    • Virginia
      • Richmond, Virginia, United States, 23298
        • Virginia Commonwealth University Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Bradycardia patients, AV Block patients, Sinus Node Dysfunction patients

Description

Inclusion Criteria:

  • Subject has a Class I or II indication for implantation of an implantable pacemaker
  • Subject (or legally authorized representative) has signed and dated the study-specific Consent Form
  • Subject is 18 years of age or older, or is of legal age to give informed consent per local and national law
  • Subject is expected to remain available for follow-up visits

Exclusion Criteria:

  • Subject is contraindicated for Cardiac CT
  • Subject has an existing or prior pacemaker, ICD or CRT device implant
  • Subject is intended to receive an implant of a LV lead or CRT device
  • Subject life expectancy is less than 1 year
  • Pregnant women or breastfeeding women, or women of child bearing potential and who are not on a reliable form of birth regulation method or abstinence
  • Subjects with exclusion criteria required by local law (e.g. age or other)
  • Subject with a medical condition that precludes the patient from participation in the opinion of the investigator
  • Subject is enrolled in a concurrent study that may confound the results of this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
His Bundle Pacing
Patient will be implanted per indications for single or dual chamber pacemaker. Lead for His bundle pacing will be implanted.
Medtronic SelectSecure SureScan MRI model 3830 lead

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant Success
Time Frame: Day of implant
To determine the proportion implant successes from all subjects who undergo an implant attempt of a lead at the bundle of His for His bundle pacing. Implant success will be defined as the presence of a H wave on the implanted lead EGM and a His-bundle pacing capture threshold equal to or less than 2.5V at 1.0ms.
Day of implant

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association Between the Lead Position and Selective vs. Nonselective HBP Occurrence at Implant
Time Frame: Day of implant
Relationship between lead position (anterior septum, mid septum, posterior septum) and His-bundle pacing selectivity (selective vs. non-selective)
Day of implant
Changes in His-bundle Pacing Capture Thresholds Over Time
Time Frame: 12 months
The change in the His-bundle pacing capture threshold from implant to 12 months
12 months
Changes in Impedance Over Time
Time Frame: 12 months
To evaluate impedance from implant to 12 months
12 months
Changes in R-wave Amplitude Over Time
Time Frame: 12 months
To evaluate R-wave amplitude from implant to 12 months
12 months
Changes in QRS Duration Over Time
Time Frame: 12 months
Intrinsic QRS duration measured prior to implant procedure and compared to measurements during follow-up
12 months
Association Between Lead Location and Long-term Lead Electrical Performance
Time Frame: 12 months
To assess the association between lead location and long-term lead electrical performance defined by the His-bundle pacing capture threshold at 12 months post-implant.
12 months
Correlation Between His-bundle Pacing Capture Threshold at Implant and Long-term Lead Electrical Performance
Time Frame: 12 months
To assess the correlation between His-bundle pacing capture threshold at implant and long-term lead electrical performance defined by the His-bundle pacing capture threshold at 12 months post-implant.
12 months
Correlation Between Paced QRS Duration at Implant and Long-term Lead Electrical Performance
Time Frame: 12 months
To assess the correlation between paced QRS duration at implant and long-term lead electrical performance defined by the His-bundle pacing capture threshold at 12 months post-implant.
12 months
Complications Related to the Procedure or the Lead for His Bundle Pacing
Time Frame: 12 months
Adverse events that are complications related to the procedure or the lead for His bundle pacing will be summarized
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pugazhendhi Vijayaraman, MD, Geisinger Wyoming Valley Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 29, 2017

Primary Completion (Actual)

April 24, 2019

Study Completion (Actual)

January 24, 2020

Study Registration Dates

First Submitted

September 22, 2017

First Submitted That Met QC Criteria

September 22, 2017

First Posted (Actual)

September 27, 2017

Study Record Updates

Last Update Posted (Actual)

June 1, 2021

Last Update Submitted That Met QC Criteria

May 28, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • IMAGE-HBP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Pacemaker, Artificial

Clinical Trials on His bundle pacing

3
Subscribe